Go to
current issue
加入关注
本刊介绍/投稿指南
催更
样式： 排序： IF: - GO 导出 标记为已读
-
Editorial: work and activity impairment are important considerations to optimise treatment plans for irritable bowel syndrome Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-08-07 Eric D. Shah, Emily V. Wechsler
LINKED CONTENT
-
Editorial: work and activity impairment are important considerations to optimise treatment plans for irritable bowel syndrome. Authors' reply Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-08-07 Vivek C. Goodoory, Cho Ee Ng, Christopher J. Black, Alexander C. Ford
LINKED CONTENT
-
Editorial: progress towards more comprehensively understanding the sources of corticosteroids for patients with IBD Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-08-07 John P. Haydek, Frank I. Scott
LINKED CONTENT
-
Editorial: progress towards more comprehensively understanding the sources of corticosteroids for patients with inflammatory bowel disease—authors' reply Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-08-07 Konstantina Rosiou, Christian P. Selinger
LINKED CONTENT
-
Editorial: further support for exclusive enteral nutrition in paediatric Crohn's disease Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-08-07 Alexandra S. Hudson, Eytan Wine
LINKED CONTENT
-
Editorial: paternal use of IBD therapies and risk of infant infection Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-08-07 Sunanda Kane
LINKED CONTENT
-
Editorial: serum triiodothyronine-to-thyroxine (T3/T4) ratio as biomarker of response in IBD - an open issue Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-08-07 Lorenzo Bertani, Domenico Tricò
LINKED CONTENT
-
Editorial: rectal hyposensitivity in patients with hypermobile Ehlers-Danlos syndrome and constipation Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-08-07 Hans Törnblom
LINKED CONTENT
-
Editorial: rectal hyposensitivity in patients with hypermobile Ehlers-Danlos syndrome and constipation—authors' reply Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-08-07 Asma Fikree, Paul F. Vollebregt, Anisa Choudhary, Qasim Aziz, S. Mark Scott
LINKED CONTENT
-
Editorial: Percutaneous placement of a permanent tunnelled catheter for patients with non-malignant ascites—Is it safe? Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-08-07 Lise Lotte Gluud, Nina Kimer, Søren Møller
LINKED CONTENT
-
Editorial: percutaneous placement of a permanent tunnelled catheter for patients with non-malignant ascites - is it safe? Authors' reply Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-08-07 Tammo L. Tergast, Benjamin Maasoumy
LINKED CONTENT
-
Editorial: pegylated interferon combined with bulevirtide for chronic hepatitis delta—new life for an old timer? Authors' reply Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-08-07 Mathias Jachs, Thomas Reiberger, Peter Ferenci
LINKED CONTENT
-
Editorial: changes in renal function and bone mineral density after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in patients with chronic hepatitis B Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-08-07 Tzu-Ning Tseng, Chien-Hung Chen
LINKED CONTENT
-
Editorial: changes in renal function and bone mineral density after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in chronic hepatitis B patients—author's reply Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-08-07 George V. Papatheodoridis
LINKED CONTENT
-
Letter: to switch or not to switch, that is the question Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-08-07 Clément Bresteau, Antoine Martin, Aurelien Amiot
LINKED CONTENT
-
Letter: to switch or not to switch, that is the question—author's reply Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-08-07 Viktoria Bergqvist, Johanna Holmgren, Daniel Klintman, Jan Marsal
LINKED CONTENT
-
Letter: long-term abdominal drains in cirrhosis – a solution or a new problem? Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-08-07 Sumita Verma
LINKED CONTENT
-
Letter: long-term abdominal drains in cirrhosis—a solution or a new problem? Authors' reply Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-08-07 Tammo L. Tergast, Benjamin Maasoumy
LINKED CONTENT
-
Corrigendum Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-08-07
In the paper entitled ‘Systematic review with meta-analysis: artificial intelligence in the diagnosis of oesophageal diseases,’1 the affiliation for Dr Cesare Hassan has been updated as below. Correct Affiliation Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20,072 Pieve Emanuele, Milan, Italy IRCCS Humanitas Research Hospital, via Manzoni 56, 20,089 Rozzano,
-
Tolerance to sterilised cow's milk in patients with eosinophilic oesophagitis triggered by milk Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-08-02 Jesús González-Cervera, Ángel Arias, Pilar Navarro, Rocío Juárez-Tosina, María Cobo-Palacios, José M. Olalla, Teresa Angueira-Lapeña, Alfredo J. Lucendo
-
Colorectal cancer in elderly-onset inflammatory bowel disease: A 1969–2017 Scandinavian register-based cohort study Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-08-02 Åsa H. Everhov, Rune Erichsen, Jacob Järås, Lars Pedersen, Jonas Halfvarson, Johan Askling, Anders Ekbom, Jonas F. Ludvigsson, Henrik Toft Sørensen, Ola Olén
-
Duodenal CD8+ T resident memory cell apoptosis contributes to gut barrier dysfunction and microbial translocation in early alcohol-associated liver disease in humans Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-08-02 Luca Maccioni, Axelle Loriot, Joseph Dewulf, Guido Bommer, Yves Horsmans, Nicolas Lanthier, Isabelle Leclercq, Bernd Schnabl, Peter Stärkel
-
Earnings during adulthood in patients with childhood-onset inflammatory bowel disease: A nationwide population-based cohort study Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-08-02 Petter Malmborg, Åsa H. Everhov, Jonas Söderling, Jonas F. Ludvigsson, Gustaf Bruze, Ola Olén
-
Therapeutic management and outcomes in inflammatory bowel diseases, 2010 to 2017 in cohorts from Denmark, Sweden and Norway Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-07-28 Mirabella Zhao, Sandre Lirhus, Mikael Lördal, Ebbe Langholz, Torben Knudsen, Markku Voutilainen, Marte Lie Høivik, Bjorn Moum, Karoline Anisdahl, Borghild Sæbø, Paula Haiko, Carolina Malmgren, Mehmet Coskun, Hans Olav Melberg, Johan Burisch
-
Review article: the epidemiologic burden of non-alcoholic fatty liver disease across the world Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-07-26 Linda Henry, James Paik, Zobair M. Younossi
-
Increasing rates of venous thromboembolism among hospitalised patients with inflammatory bowel disease: a nationwide analysis Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-07-25 Adam S. Faye, Kate E. Lee, John Dodson, Joshua Chodosh, David Hudesman, Feza Remzi, Jason D. Wright, Alexander M. Friedman, Aasma Shaukat, Timothy Wen
-
Editorial: refractory reflux sensitivity - a place for baclofen? Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-07-25 Philip O. Katz
LINKED CONTENT
-
Editorial: refractory reflux sensitivity—A place for baclofen? Authors' reply Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-07-25 Karlien Raymenants, Jan Tack
LINKED CONTENT
-
Editorial: non-invasive testing for EoE—does microbiome testing hold the key? Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-07-25 Rishi D. Naik, Dhyanesh A. Patel
LINKED CONTENT
-
Editorial: non-invasive testing for EoE—does microbiome testing hold the key? Authors' reply Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-07-25 Sonia Facchin, Matteo Calgaro, Mattia Pandolfo, Federico Caldart, Matteo Ghisa, Nicola Vitulo, Edoardo Vincenzo Savarino
LINKED CONTENT
-
Editorial: effectiveness and safety of vedolizumab in a matched cohort of elderly and non-elderly patients with inflammatory bowel disease - the IG-IBD LIVE study Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-07-25 Helen Lee, Nabeel Khan
LINKED CONTENT
-
Editorial: effectiveness and safety of vedolizumab in a matched cohort of elderly and non-elderly patients with inflammatory bowel disease—the IG-IBD LIVE study. Authors' reply Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-07-25 Daniela Pugliese, Giuseppe Privitera, Alessandro Armuzzi
LINKED CONTENT
-
Editorial: golimumab thresholds to achieve stringent medium- and long-term therapeutic outcomes in patients with ulcerative colitis Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-07-25 Gerassimos J. Mantzaris, Konstantinos Papamichael
LINKED CONTENT
-
Editorial: golimumab thresholds to achieve stringent medium- and long-term therapeutic outcomes in patients with ulcerative colitis—Author’s reply Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-07-25 Carlos Taxonera
LINKED CONTENT
-
Editorial: a formula shake each day keeps the complications away – the tolerability and effect of orally-delivered enteral nutrition in improving post-operative outcomes in patients with Crohn's disease Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-07-25 Stephanie L. Gold, Maitreyi Raman
LINKED CONTENT
-
Editorial: quality assessment in IBD in high-resource countries can lead to quality improvement clues for IBD management worldwide Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-07-25 Charles N. Bernstein
LINKED CONTENT
-
Editorial: quality assessment in IBD in high resource countries can lead to quality improvement clues for IBD management worldwide—authors' reply Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-07-25 A. Barney Hawthorne, Christopher A. Lamb
LINKED CONTENT
-
Editorial: measuring disease severity in inflammatory bowel disease—the whole is greater than the sum of its parts Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-07-25 Laurie Keefer, Mara J. Shapiro
LINKED CONTENT
-
Editorial: measuring disease severity in inflammatory bowel disease—the whole is greater than the sum of its parts. Authors' reply Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-07-25 Akhilesh Swaminathan, Thomas C. Mules, Richard B. Gearry
LINKED CONTENT
-
Editorial: non-viral hepatocellular carcinoma surveillance—an increasingly severe public health issue Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-07-25 Li-Yang Sun, Zhen-Li Li, Tian Yang
LINKED CONTENT
-
Editorial: non-viral hepatocellular carcinoma surveillance—an increasingly severe public health issue. Authors' reply Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-07-25 Hidenori Toyoda, Kazuya Kariyama, Atsushi Hiraoka
LINKED CONTENT
-
Letter: a promising Helicobacter pylori regimen - vonoprazan-based therapy Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-07-25 Yi Hu, Nong-Hua Lu
LINKED CONTENT
-
Letter: a promising Helicobacter pylori regimen—vonoprazan-based therapy. Author’s reply Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-07-25 Daphne Ang
LINKED CONTENT
-
TRIM26 inhibits hepatitis B virus replication by promoting HBx degradation and TRIM26 genetic polymorphism predicts PegIFNα treatment response of HBeAg-positive chronic hepatitis B Patients Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-07-24 Mengqi Luo, Jia Hou, Haoming Mai, Jiaxuan Chen, Haitao Chen, Bin Zhou, Jinlin Hou, De-Ke Jiang
-
Real-world experience of switching from intravenous to subcutaneous vedolizumab maintenance treatment for inflammatory bowel diseases Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-07-23 Adriaan Volkers, Tessa Straatmijer, Marjolijn Duijvestein, Amber Sales, Amit Levran, Fiona van Schaik, Jeroen Maljaars, Krisztina Gecse, Cyriel Ponsioen, Joep Grootjans, Jurij Hanzel, Greetje Tack, Jeroen Jansen, Frank Hoentjen, Nanne de Boer, Sander van der Marel, Gerard Dijkstra, Bas Oldenburg, Mark Löwenberg, Andrea van der Meulen, Geert D′Haens
-
Transmural healing evaluated by magnetic resonance enterography in paediatric patients with Crohn's disease receiving maintenance treatment with biologics Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-07-23 So Yoon Choi, Eun Sil Kim, Tae Yeon Jeon, Yoo Min Lee, So Mi Lee, Byung-Ho Choe, Yon Ho Choe, Ben Kang
-
Universal HBV vaccination dramatically reduces the prevalence of HBV infection and incidence of hepatocellular carcinoma Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-07-21 Grace Lai-Hung Wong, Vicki Wing-Ki Hui, Terry Cheuk-Fung Yip, Lilian Yan Liang, Xinrong Zhang, Yee-Kit Tse, Jimmy Che-To Lai, Henry Lik-Yuen Chan, Vincent Wai-Sun Wong
-
Sugar-sweetened beverages, artificially sweetened beverages and natural juices and risk of inflammatory bowel disease: a cohort study of 121,490 participants Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-07-18 Tian Fu, Hui Chen, Xuejie Chen, Yuhao Sun, Ying Xie, Minzi Deng, Therese Hesketh, Xiaoyan Wang, Jie Chen
-
Editorial: tradipitant has promise for treating gastroparesis but leaves gastric function alone Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-07-08 Eli D. Ehrenpreis, David H. Kruchko
This article is linked to Khanna et al papers. To view these articles, visit https://doi.org/10.1111/apt.17065
-
Editorial: tradipitant has promise for treating gastroparesis but leaves gastric function alone—authors’ reply Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-07-08 Michael Camilleri, Ting Zheng
This article is linked to Khanna et al papers. To view these articles, visit https://doi.org/10.1111/apt.17065
-
Editorial: is functional cure the only holy grail for treatment discontinuation in patients with HBeAg-negative chronic hepatitis B? Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-07-08 Yen-Chun Liu, Wen-Juei Jeng
This article is linked to Hall et al papers. To view these articles, visit https://doi.org/10.1111/apt.16968
-
Plasma and breast milk pharmacokinetics of tenofovir alafenamide in mothers with chronic hepatitis B infection Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-07-08 Mei-Hsuan Lee
This article is linked to Kayes et al papers. To view these articles, visit https://doi.org/10.1111/apt.17040
-
Plasma and breast milk pharmacokinetics of tenofovir alafenamide of mothers with chronic hepatitis B infection—Authors' reply Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-07-08 Miriam T. Levy, Angela Kashuba, Edward Gane
This article is linked to Kayes et al papers. To view these articles, visit https://doi.org/10.1111/apt.17040
-
Editorial: dying while waiting for a hepatitis B cure? Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-07-08 Gonzague Jourdain, Nuttada Panpradist
This article is linked to Lim et al papers. To view these articles, visit https://doi.org/10.1111/apt.17052
-
Letter: sex disparities in presentation and prognosis of 1110 patients with hepatocellular carcinoma Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-07-08 Li-Yang Sun, Hang-Dong Jia, Lei Liang, Dong-Sheng Huang, Tian Yang
This article is linked to El-Khateeb et al papers. To view these articles, visit https://doi.org/10.1111/apt.16489
-
Classic drugs in the time of new drugs: Real-world, long-term outcomes of thiopurine monotherapy in 1016 patients with inflammatory bowel disease Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-07-06 Ashkan Rezazadeh Ardabili, Steven Jeuring, Zlatan Mujagic, Liekele Oostenbrug, Mariëlle Romberg-Camps, Daisy Jonkers, Adriaan van Bodegraven, Marieke Pierik
-
Treatment patterns of anti-tumour necrosis factor-alpha and prognosis of paediatric and adult-onset inflammatory bowel disease in Korea: a nationwide population-based study Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-07-06 Young June Choe, Kyoungdo Han, Jung Ok Shim
-
Impact of Rome IV irritable bowel syndrome on work and activities of daily living Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-07-06 Vivek C. Goodoory, Cho Ee Ng, Christopher J. Black, Alexander C. Ford
-
Living in the non-alcoholic fatty liver disease silent epidemic: a qualitative systematic review of patients' perspectives Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-07-06 Cheng Han Ng, Wen Hui Lim, Yip Han Chin, Jie Ning Yong, Rebecca Wenling Zeng, Kai En Chan, Darren Jun Hao Tan, Clarissa Elysia Fu, Ansel Shao Pin Tang, Lay Hoon Goh, Kamala Devi, Nicholas W. S. Chew, Lung-Yi Loey Mak, Nobuharu Tamaki, Daniel Q. Huang, Mazen Noureddin, Mohammad Shadab Siddiqui, Rohit Loomba, Arun J. Sanyal, Mark Muthiah
-
Impact of thiopurines and tumour necrosis factor antagonists on primary sclerosing cholangitis outcomes in patients with inflammatory bowel disease Aliment. Pharm. Ther. (IF 9.524) Pub Date : 2022-07-04 Amélie Biron, Laurent Beaugerie, Olivier Chazouillères, Julien Kirchgesner
更新日期：2022-08-02
京公网安备 11010802027423号